Rustem Airatovich Gafanov (Rustem Gafanov, Rustem A Gafanov)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Mesenchymal Stem Cells

Radiation Therapy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, Sang Joon Shin, Jae Lyun Lee, Niven Mehra, Ray S McDermott, Núria Sala-Gonzalez, Peter C Fong, Richard Greil, Margitta Retz, Juan Pablo Sade, Patricio Yanez, Eric Yi-Hsiu Huang, Stephen D Begbie, Rustem Airatovich Gafanov, Maria De Santis, Eli Rosenbaum, Michael P Kolinsky, Felipe Rey, Kun-Yuan Chiu, Guilhem Roubaud, Gero Kramer, Makoto Sumitomo, Francesco Massari, Hiroyoshi Suzuki, Ping Qiu, Jinchun Zhang, Jeri Kim, Christian H Poehlein, Evan Y Yu
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
David F McDermott, Jae Lyun Lee, Georg Arnold Bjarnason, James M G Larkin, Rustem Airatovich Gafanov, Mark D Kochenderfer, Niels Viggo Jensen, Frede Donskov, Jahangeer Malik, Alexandr Poprach, Scott S Tykodi, Teresa Alonso-Gordoa, Daniel C Cho, Poul F Geertsen, Miguel Angel Climent Duran, Christopher DiSimone, Rachel Kloss Silverman, Rodolfo F Perini, Charles Schloss, Michael B Atkins
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
Daniel P Petrylak, Raffaele Ratta, Rustem Airatovich Gafanov, Gaetano Facchini, Josep Maria Piulats, Gero Kramer, Thomas W Flaig, Sreenivasa R Chandana, Ben Li, Joseph Burgents, Karim Fizazi
KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer. Future oncology (London, England) 17 (25) (2021)
David F McDermott, Jae Lyun Lee, Marek Ziobro, Cristina Suarez, Przemyslaw Langiewicz, Vsevolod Borisovich Matveev, Pawel Wiechno, Rustem Airatovich Gafanov, Piotr Tomczak, Frederic Pouliot, Frede Donskov, Boris Yakovlevich Alekseev, Sang Joon Shin, Georg Arnold Bjarnason, Daniel Castellano, Rachel Kloss Silverman, Rodolfo F Perini, Charles Schloss, Michael B Atkins
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)